The ACR—along with seven other radiology organizations—said thousands could die due to delayed diagnoses caused by the pandemic and urged governors to take action.

Less than half the U.S. public is OK with physicians giving hospital patients’ names to hospital development departments—and that’s after the doctors ask the patients for permission.

The Centers for Medicare & Medicaid Services first suspended most fee-for-service reviews back in March because of the pandemic.

ELVIS, it seems, has entered the operating room. 

Korean researchers tested the traditional LI-RADS algorithm and a modified version in nearly 140 patients with liver cancer, sharing their findings in Radiology.

The $400,000 outlay came at a time when overall lobbying across the healthcare sector plummeted, according to a recent analysis. 

The ThyrAMI-2 trial tracked 95 patients for 52 weeks of treatment. 

As Congress gets to work following its Independence Day break, provider lobbyists are pushing hard for a fifth relief package to stem the bleeding from widespread declines in patient visits. 

ACR President Geraldine McGinty, MD, MBA, detailed planning advice from her own institution in a new opinion piece, published in JACR. 

Blue Earth Diagnostics announced that it has administered its new radiohybrid imaging agent to patients taking part in a clinical trial for prostate cancer.